H49.4
Progressive external ophthalmoplegia
Clinical Classification Guidelines
Excludes Type 1
- Kearns-Sayre syndrome (H49.81-)
Medical Intelligence & Overview
Progressive External Ophthalmoplegia (PEO) is a condition characterized by the gradual weakening and paralysis of the eye muscles that control eye movement and eyelid elevation. This condition typically develops slowly over time, leading to difficulties with eye coordination, drooping eyelids (ptosis), and problems with vision. PEO can occur on its own or be associated with other neurological or muscular disorders. It is classified under ICD-10 code H49.4, emphasizing its distinct features related to eye movement impairment.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting mitochondrial DNA, impacting energy production in muscle cells Inherited mitochondrial myopathies, passed down through families Acquired mitochondrial dysfunction due to environmental factors or other illnesses Associated syndromes such as Kearns-Sayre syndrome or CPEO plus, which involve additional systemic manifestations
Key Symptoms: Gradual weakness of the muscles around the eyes, leading to limited eye movement in multiple directions Drooping eyelids (ptosis), often worsening over time and sometimes causing visual obstruction Double vision (diplopia), caused by misalignment of the eyes Difficulty in moving the eyes upward, downward, or sideways Possible facial muscle weakness or weakness in other muscle groups in some cases Ocular fatigue, especially after sustained use of the eyes
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a combination of clinical evaluation and specialized tests. Eye movement examinations reveal restricted eye mobility and ptosis. Additional assessments may include: - Electromyography (EMG) to evaluate muscle function - Blood tests for muscle enzymes and genetic testing to detect mitochondrial DNA mutations - Imaging studies such as MRI or CT scans to rule out other neurological causes - Muscle biopsy in certain cases to examine cellular and mitochondrial health A comprehensive evaluation helps confirm the diagnosis and rule out other causes of eye muscle weakness.
Treatment Protocols: Currently, there is no cure for Progressive External Ophthalmoplegia. Management primarily focuses on symptom relief and improving quality of life. Treatment options may include: - Corrective surgery for ptosis to improve eyelid position and vision - Prism glasses to reduce double vision - Use of eyeglasses with prisms or patching strategies - Supportive therapies such as physical or occupational therapy to strengthen surrounding muscles - Regular monitoring for associated systemic conditions or complications - Genetic counseling for affected families to understand inheritance patterns While treatments can help manage symptoms, ongoing medical care is essential to address evolving issues related to PEO.
Clinical Advice & FAQs
Billing Guidance
Is H49.4 a billable ICD-10 code?
Yes, H49.4 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H49.4?
Clinical documentation must specify the nature of Progressive external ophthalmoplegia and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
